» Articles » PMID: 39235594

Rapid Quantitative High-throughput Mouse Embryoid Body Model for Embryotoxicity Assessment

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2024 Sep 5
PMID 39235594
Authors
Affiliations
Soon will be listed here.
Abstract

Individuals are exposed to a wide arrays of hazardous chemicals on a daily basis through various routes, many of which have not undergone comprehensive toxicity assessments. While traditional developmental toxicity tests involving pregnant animals are known for their reliability, they are also associated with high costs and time requirements. Consequently, there is an urgent demand for alternative, cost-efficient, and rapid in vitro testing methods. This study aims to address the challenges related to automating and streamlining the screening of early developmental toxicity of chemicals by introducing a mouse embryoid body test (EBT) model in a 384-ultra low attachment well format. Embryoid bodies (EBs) generated in this format were characterized by a spontaneous differentiation trajectory into cardiac mesoderm by as analyzed by RNA-seq. Assessing prediction accuracy using reference compounds suggested in the ICH S5(R3) guideline and prior studies resulted in the establishment of the acceptance criteria and applicability domain of the EBT model. The results indicated an 84.38% accuracy in predicting the developmental toxicity of 23 positive and 9 negative reference compounds, with an optimized cutoff threshold of 750 µM. Overall, the developed EBT model presents a promising approach for more rapid, high-throughput chemical screening, thereby facilitating well-informed decision-making in environmental management and safety assessments.

Citing Articles

Embryoid Body Test: A Simple and Reliable Alternative Developmental Toxicity Test.

Hwang I, Jeung E Int J Mol Sci. 2025; 25(24.

PMID: 39769329 PMC: 11676132. DOI: 10.3390/ijms252413566.

References
1.
Barnes R, Firulli B, VanDusen N, Morikawa Y, Conway S, Cserjesi P . Hand2 loss-of-function in Hand1-expressing cells reveals distinct roles in epicardial and coronary vessel development. Circ Res. 2011; 108(8):940-9. PMC: 3086599. DOI: 10.1161/CIRCRESAHA.110.233171. View

2.
Barrier M, Jeffay S, Nichols H, Chandler K, Hoopes M, Slentz-Kesler K . Mouse embryonic stem cell adherent cell differentiation and cytotoxicity (ACDC) assay. Reprod Toxicol. 2011; 31(4):383-91. DOI: 10.1016/j.reprotox.2011.01.007. View

3.
Buesen R, Genschow E, Slawik B, Visan A, Spielmann H, Luch A . Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicol Sci. 2009; 108(2):389-400. DOI: 10.1093/toxsci/kfp012. View

4.
Choy Buentello D, Koch L, Trujillo-de Santiago G, Alvarez M, Broersen K . Use of standard U-bottom and V-bottom well plates to generate neuroepithelial embryoid bodies. PLoS One. 2022; 17(5):e0262062. PMC: 9089918. DOI: 10.1371/journal.pone.0262062. View

5.
Genschow E, Spielmann H, Scholz G, Pohl I, Seiler A, Clemann N . Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim. 2004; 32(3):209-44. DOI: 10.1177/026119290403200305. View